Target intelligence / Profile preview

Gut microbiome ecological network

Molecular classification
Other
01

Overview

The gut microbiome ecological network is not a single molecular target but a conceptual and analytical framework for representing the complex interactions among the diverse microbial species inhabiting the human gastrointestinal tract[1][5][6]. These networks capture symbiotic, competitive, and commensal relationships among bacteria, fungi, archaea, viruses, and other microorganisms, reflecting their roles in digestion, immune regulation, maintenance of epithelial integrity, and resistance to pathogens[1][4][5]. Network-based analysis is used to identify key species and associations relevant to health and disease, monitor community stability, and explore how perturbations can lead to dysbiosis and disease[1][5][6]. While this ecological network perspective is invaluable for research, it does not correspond to a distinct therapeutic target like a receptor, enzyme, or transporter; rather, it is an emergent property of the entire communal ecosystem. As such, interventions target the microbial community as a whole (e.g., via probiotics, prebiotics, antibiotics, dietary changes), not specific molecular targets. This entry is considered incorrect as a classical therapeutic target: - It does not correspond to a discrete molecule, protein, or gene. - It cannot be directly targeted by small molecules or biologics in the conventional pharmacological sense. - Drugs do not act on the “network” itself, but rather influence the abundance, activity, or composition of specific microbial species or groups within this network[4]. For structured target databases, this term should be flagged for curation or clarified into specific microbial species, pathways, or host-microbe interaction molecules if actionable therapeutically.

Other names
gut microbial ecological networkgut microecological networkintestinal microbiome ecological network
02

Biological functions

Nutrient digestion and metabolismImmune system modulationMaintenance of epithelial barrier functionResistance to pathogen colonizationMetabolite productionRegulation of inflammation
03

Disease associations

InflammationInfectionMetabolic disorders (e.g., obesity, diabetes)Inflammatory bowel diseaseOther (e.g., cardiovascular, neurodegenerative diseases via host-microbe interactions)
04

Safety considerations

Complexity in response to interventions (difficulty predicting outcomes)Risk of dysbiosis after perturbations (e.g., antibiotics, dietary change)Unintended off-target effects of microbiome-modulating interventions

Beyond the preview

Go deeper on Gut microbiome ecological network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiome ecological network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call